Purple Biotech Presents CAPTN-3 Data at EORTC-NCI-AACR
Ticker: PPBT · Form: 6-K · Filed: Oct 25, 2024 · CIK: 1614744
Sentiment: neutral
Topics: biotech, data-presentation, oncology, antibody-platform
TL;DR
Purple Biotech dropped new data on its CAPTN-3 antibody platform at a major cancer conference.
AI Summary
On October 25, 2024, Purple Biotech Ltd. announced new data for its CAPTN-3 antibody platform, which targets tri-specific T cell and NK cell engagers. This presentation occurred at the EORTC-NCI-AACR Symposium. The company, formerly known as Kitov Pharma Ltd., is based in Rehovot, Israel.
Why It Matters
The presentation of new data for the CAPTN-3 platform could advance Purple Biotech's pipeline of novel cancer therapies, potentially impacting future treatment options.
Risk Assessment
Risk Level: medium — Biotech companies often carry medium risk due to the inherent uncertainties in drug development and clinical trials.
Key Players & Entities
- Purple Biotech Ltd. (company) — Filer and presenter of data
- CAPTN-3 (platform) — Novel antibody platform
- EORTC-NCI-AACR (conference) — Symposium where data was presented
- Kitov Pharma Ltd. (company) — Former company name
- October 25, 2024 (date) — Date of press release and presentation
FAQ
What specific new data was presented for the CAPTN-3 platform?
The filing states that new data was presented, but does not specify the exact nature or results of this data.
What is the significance of presenting at the EORTC-NCI-AACR Symposium?
This symposium is a major event for cancer research, suggesting the data presented is relevant to the oncology community.
What are tri-specific T cell and NK cell engagers?
These are novel antibody constructs designed to engage both T cells and Natural Killer (NK) cells to target cancer cells.
When did Purple Biotech Ltd. change its name from Kitov Pharma Ltd.?
The filing indicates a name change from Kitov Pharma Ltd. occurred on January 25, 2018.
Where is Purple Biotech Ltd. headquartered?
Purple Biotech Ltd. is headquartered at 4 Oppenheimer Street, Science Park, Rehovot, Israel.
Filing Stats: 583 words · 2 min read · ~2 pages · Grade level 20 · Accepted 2024-10-25 07:20:40
Filing Documents
- ea0218643-6k_purple.htm (6-K) — 14KB
- ea021864301ex99-1_purple.htm (EX-99.1) — 22KB
- 0001213900-24-090521.txt ( ) — 37KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. October 25, 2024 PURPLE BIOTECH LTD. By: /s/ Gil Efron Gil Efron Chief Executive Officer 2